RADX Annual Interest Expense
$421.50 K
+$363.60 K+627.98%
01 June 2024
Summary:
As of January 30, 2025, RADX annual interest expense is $421.50 thousand, with the most recent change of +$363.60 thousand (+627.98%) on June 1, 2024. During the last 3 years, it has fallen by -$6.36 million (-93.78%). RADX annual interest expense is now -93.78% below its all-time high of $6.78 million, reached on June 1, 2022.RADX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RADX Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +628.0% | - | - |
3 y3 years | -93.8% | - | - |
5 y5 years | -93.8% | - | - |
RADX Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -93.8% | +628.0% | ||||
5 y | 5-year | -93.8% | +628.0% | ||||
alltime | all time | -93.8% | +628.0% |
Radiopharm Theranostics Limited Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | $421.50 K(+628.0%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | $57.90 K(-99.1%) | - | - |
June 2022 | $6.78 M | - | - |
FAQ
- What is Radiopharm Theranostics Limited annual interest expense?
- What is the all time high annual interest expense for Radiopharm Theranostics Limited?
- What is Radiopharm Theranostics Limited annual interest expense year-on-year change?
What is Radiopharm Theranostics Limited annual interest expense?
The current annual interest expense of RADX is $421.50 K
What is the all time high annual interest expense for Radiopharm Theranostics Limited?
Radiopharm Theranostics Limited all-time high annual interest expense is $6.78 M
What is Radiopharm Theranostics Limited annual interest expense year-on-year change?
Over the past year, RADX annual interest expense has changed by +$363.60 K (+627.98%)